VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $183.15)
- $183.15 P/E (TTM): 22.72X Cap: $364M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $167.27)
- $167.27 P/E (TTM): 23.15X Cap: $8.13B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $45.37)
- $45.37 Cap: $18.21B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $183.15)
- $183.15 P/E (TTM): 22.72X Cap: $364M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $167.27)
- $167.27 P/E (TTM): 23.15X Cap: $8.13B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $51.63)
- $51.63 Cap: $5.04B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $183.15)
- $183.15 P/E (TTM): 22.72X Cap: $364M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $701.42)
- $701.42 P/E (TTM): 16.55X Cap: $74.12B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $227.19)
- $227.19 P/E (TTM): 20.61X Cap: $553.29B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $963.33)
- $963.33 P/E (TTM): 37.09X Cap: $883.02B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $112.16)
- $112.16 P/E (TTM): 15.24X Cap: $269.81B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $26.33)
- $26.33 P/E (TTM): 19.31X Cap: $149.77B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $469.21)
- $469.21 P/E (TTM): 26.28X Cap: $174.30B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $43.88)
- $43.88 P/E (TTM): 11.15X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $167.27)
- $167.27 P/E (TTM): 23.15X Cap: $8.13B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $45.37)
- $45.37 Cap: $18.21B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $183.15)
- $183.15 P/E (TTM): 22.72X Cap: $364M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $88.00)
- $88.00 P/E (TTM): 22.12X Cap: $941M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023